Symbols / INTS Stock $5.25 -0.47% Intensity Therapeutics, Inc.
INTS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Ratings
Current target
$5.25
Low
$12.00
High
$125.00
Mean
$41.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-20 | main | Benchmark | Speculative Buy → Speculative Buy | $2 |
| 2025-08-12 | up | Brookline Capital | Hold → Buy | $3 |
| 2025-01-13 | init | Alliance Global Partners | — → Buy | $9 |
| 2024-11-21 | reit | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-10-31 | init | HC Wainwright & Co. | — → Buy | $5 |
| 2024-07-11 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2024-05-16 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2024-03-21 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-11-14 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-08-24 | reit | Benchmark | Speculative Buy → Speculative Buy | $12 |
| 2023-07-18 | init | Benchmark | — → Speculative Buy | $12 |
- Intensity Therapeutics Announces Reverse Stock Split - PR Newswire Fri, 13 Feb 2026 08
- Intensity Therapeutics Inc. (INTS) upgraded to buy: Here's what you should know - MSN Sun, 26 Apr 2026 02
- Why Did INTS Stock Plummet 25% Today? - Stocktwits Fri, 13 Feb 2026 14
- INTS Stock Price and Chart — NASDAQ:INTS - TradingView Fri, 31 Oct 2025 07
- Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock - PR Newswire Fri, 31 Oct 2025 07
- Intensity’s tumor-injection platform wins platinum biotech award - Stock Titan Wed, 15 Apr 2026 07
- Intensity Therapeutics (INTS) price target decreased by 11.32% to 57.29 - MSN Sun, 26 Apr 2026 03
- Intensity Therapeutics (NASDAQ: INTS) boosts $60M at-the-market capacity - Stock Titan Mon, 23 Mar 2026 07
- Trial in aggressive breast cancer sees 44% fewer severe side effects - Stock Titan hu, 12 Mar 2026 07
- Intensity Therapeutics Reports 2025 Year End Financial Results and Highlights, and Provides Corporate Update - PR Newswire Fri, 27 Mar 2026 07
- INTS (Intensity) reports slight Q4 2025 EPS miss, shares edge higher with no quarterly revenue posted. - Acquisition - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- Intensity Therapeutics (INTS) Stock Analysis Report | Financials & Insights - Benzinga Wed, 15 Apr 2026 07
- Intensity Therapeutics (INTS) CEO receives 37,749-share stock bonus grant - Stock Titan Mon, 30 Mar 2026 07
- Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire hu, 07 Aug 2025 07
- Intensity Therapeutics (Nasdaq: INTS) reports 11.9-month OS; INT230-6 in eBioMedicine - Stock Titan hu, 30 Oct 2025 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
11.97
-27.81%
|
16.59
+99.36%
|
8.32
+10.19%
|
7.55
|
| Research And Development |
|
6.79
-35.36%
|
10.50
+119.31%
|
4.79
-6.74%
|
5.13
|
| Selling General And Administration |
|
5.19
-14.81%
|
6.09
+72.35%
|
3.53
+46.11%
|
2.42
|
| General And Administrative Expense |
|
5.19
-14.81%
|
6.09
+72.35%
|
3.53
+46.11%
|
2.42
|
| Salaries And Wages |
|
2.64
-2.69%
|
2.72
+118.58%
|
1.24
+76.31%
|
0.70
|
| Other Gand A |
|
1.87
-25.02%
|
2.50
+48.51%
|
1.68
+2.69%
|
1.64
|
| Total Expenses |
|
11.97
-27.81%
|
16.59
+99.36%
|
8.32
+10.19%
|
7.55
|
| Operating Income |
|
-11.97
+27.81%
|
-16.59
-99.36%
|
-8.32
-10.19%
|
-7.55
|
| Total Operating Income As Reported |
|
-11.97
+27.81%
|
-16.59
-99.36%
|
-8.32
-10.19%
|
-7.55
|
| EBITDA |
|
-11.97
+27.81%
|
-16.59
-62.07%
|
-10.23
-36.44%
|
-7.50
|
| Normalized EBITDA |
|
-11.97
+27.81%
|
-16.59
-108.07%
|
-7.97
-6.28%
|
-7.50
|
| EBIT |
|
-11.97
+27.81%
|
-16.59
-62.07%
|
-10.23
-36.44%
|
-7.50
|
| Total Unusual Items |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Special Income Charges |
|
—
|
0.00
+100.00%
|
-2.26
|
0.00
|
| Other Special Charges |
|
—
|
—
|
2.26
|
—
|
| Net Income |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Pretax Income |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Non Operating Interest Income Expense |
|
0.18
-42.68%
|
0.31
+1552.63%
|
0.02
+123.75%
|
-0.08
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
0.30
+271.95%
|
0.08
|
| Net Interest Income |
|
0.18
-42.68%
|
0.31
+1552.63%
|
0.02
+123.75%
|
-0.08
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
0.30
+271.95%
|
0.08
|
| Interest Income Non Operating |
|
0.18
-42.68%
|
0.31
-3.09%
|
0.32
+16100.00%
|
0.00
|
| Interest Income |
|
0.18
-42.68%
|
0.31
-3.09%
|
0.32
+16100.00%
|
0.00
|
| Other Income Expense |
|
0.19
+6100.00%
|
0.00
+100.13%
|
-2.24
-4762.50%
|
0.05
|
| Other Non Operating Income Expenses |
|
0.19
+6100.00%
|
0.00
-87.50%
|
0.02
-50.00%
|
0.05
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income From Continuing Operation Net Minority Interest |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income From Continuing And Discontinued Operation |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Net Income Continuous Operations |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Normalized Income |
|
-11.61
+28.66%
|
-16.27
-96.57%
|
-8.28
-9.15%
|
-7.58
|
| Net Income Common Stockholders |
|
-11.61
+28.66%
|
-16.27
-37.14%
|
-11.86
-56.45%
|
-7.58
|
| Diluted EPS |
|
-8.56
+70.73%
|
-29.24
+15.25%
|
-34.50
+36.96%
|
-54.73
|
| Basic EPS |
|
-8.56
+70.73%
|
-29.24
+15.25%
|
-34.50
+36.96%
|
-54.73
|
| Basic Average Shares |
|
1.36
+143.83%
|
0.56
+61.40%
|
0.34
+148.77%
|
0.14
|
| Diluted Average Shares |
|
1.36
+143.83%
|
0.56
+61.40%
|
0.34
-34.22%
|
0.52
|
| Diluted NI Availto Com Stockholders |
|
-11.61
+28.66%
|
-16.27
-37.14%
|
-11.86
-56.45%
|
-7.58
|
| Insurance And Claims |
|
0.67
-23.34%
|
0.87
+43.75%
|
0.61
+710.67%
|
0.07
|
| Preferred Stock Dividends |
|
—
|
—
|
1.32
|
—
|
| Rent And Landing Fees |
|
—
|
—
|
—
|
0.14
|
| Rent Expense Supplemental |
|
—
|
—
|
—
|
0.14
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14.10
+194.81%
|
4.78
-72.34%
|
17.30
+884.35%
|
1.76
|
| Current Assets |
|
12.71
+277.91%
|
3.36
-78.25%
|
15.46
+965.75%
|
1.45
|
| Cash Cash Equivalents And Short Term Investments |
|
11.92
+360.27%
|
2.59
-82.47%
|
14.78
+1026.22%
|
1.31
|
| Cash And Cash Equivalents |
|
11.92
+360.27%
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
|
| Cash Equivalents |
|
11.84
+447.41%
|
2.16
-73.60%
|
8.19
|
0.00
|
| Cash Financial |
|
0.09
-79.91%
|
0.43
+16.62%
|
0.37
-72.03%
|
1.31
|
| Other Short Term Investments |
|
—
|
0.00
-100.00%
|
6.22
|
0.00
|
| Receivables |
|
—
|
—
|
—
|
0.06
|
| Taxes Receivable |
|
—
|
—
|
—
|
0.02
|
| Prepaid Assets |
|
0.79
+1.94%
|
0.77
+12.35%
|
0.69
+992.06%
|
0.06
|
| Other Current Assets |
|
—
|
—
|
0.01
-92.11%
|
0.08
|
| Total Non Current Assets |
|
1.39
-1.97%
|
1.42
-22.45%
|
1.83
+498.37%
|
0.31
|
| Net PPE |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Gross PPE |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Other Properties |
|
0.10
-21.31%
|
0.12
-17.01%
|
0.15
+5.76%
|
0.14
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
0.17
|
| Other Non Current Assets |
|
1.30
-0.15%
|
1.30
-22.92%
|
1.68
+908.38%
|
0.17
|
| Total Liabilities Net Minority Interest |
|
2.23
+19.30%
|
1.86
-54.88%
|
4.13
-75.48%
|
16.86
|
| Current Liabilities |
|
2.15
+22.28%
|
1.75
-55.67%
|
3.96
-41.94%
|
6.82
|
| Payables And Accrued Expenses |
|
1.31
-21.30%
|
1.67
-52.89%
|
3.55
+52.43%
|
2.33
|
| Payables |
|
0.58
-52.17%
|
1.22
-60.01%
|
3.05
+405.47%
|
0.60
|
| Accounts Payable |
|
0.58
-52.17%
|
1.22
-60.01%
|
3.05
+405.47%
|
0.60
|
| Current Accrued Expenses |
|
0.73
+61.95%
|
0.45
-9.42%
|
0.50
-71.06%
|
1.72
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.80
+1328.57%
|
0.06
-85.71%
|
0.39
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.03
+10.71%
|
0.03
+40.00%
|
0.02
-99.55%
|
4.49
|
| Current Debt |
|
—
|
—
|
—
|
4.35
|
| Other Current Borrowings |
|
—
|
—
|
—
|
4.35
|
| Current Capital Lease Obligation |
|
0.03
+10.71%
|
0.03
+40.00%
|
0.02
-86.01%
|
0.14
|
| Total Non Current Liabilities Net Minority Interest |
|
0.08
-28.18%
|
0.11
-36.78%
|
0.17
-98.27%
|
10.04
|
| Long Term Debt And Capital Lease Obligation |
|
0.08
-28.18%
|
0.11
-20.29%
|
0.14
|
0.00
|
| Long Term Capital Lease Obligation |
|
0.08
-28.18%
|
0.11
-20.29%
|
0.14
|
0.00
|
| Other Non Current Liabilities |
|
—
|
—
|
0.04
+0.00%
|
0.04
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
0.00
-100.00%
|
10.00
|
| Stockholders Equity |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Common Stock Equity |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
0.00
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
2.52
+317.33%
|
0.60
+10.31%
|
0.55
+4.66%
|
0.52
|
| Ordinary Shares Number |
|
2.52
+317.33%
|
0.60
+10.31%
|
0.55
+4.66%
|
0.52
|
| Additional Paid In Capital |
|
90.27
+29.50%
|
69.70
+9.46%
|
63.68
+170.33%
|
23.55
|
| Retained Earnings |
|
-78.39
-17.38%
|
-66.78
-32.20%
|
-50.52
-30.69%
|
-38.65
|
| Total Equity Gross Minority Interest |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Total Capitalization |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Working Capital |
|
10.56
+556.90%
|
1.61
-86.02%
|
11.51
+314.33%
|
-5.37
|
| Invested Capital |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+222.45%
|
-10.75
|
| Total Debt |
|
0.11
-20.29%
|
0.14
-12.66%
|
0.16
-96.48%
|
4.49
|
| Net Debt |
|
—
|
—
|
—
|
3.04
|
| Capital Lease Obligations |
|
0.11
-20.29%
|
0.14
-12.66%
|
0.16
+10.49%
|
0.14
|
| Net Tangible Assets |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Tangible Book Value |
|
11.88
+306.99%
|
2.92
-77.83%
|
13.16
+187.18%
|
-15.10
|
| Duefrom Related Parties Current |
|
—
|
—
|
—
|
0.05
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Cash Flow From Continuing Operating Activities |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Net Income From Continuing Operations |
|
-11.61
+28.66%
|
-16.27
-54.37%
|
-10.54
-38.99%
|
-7.58
|
| Other Non Cash Items |
|
0.03
+144.83%
|
-0.06
-153.21%
|
0.11
-39.11%
|
0.18
|
| Stock Based Compensation |
|
2.00
-34.92%
|
3.07
+119.81%
|
1.40
+19.59%
|
1.17
|
| Operating Gains Losses |
|
—
|
—
|
2.26
|
—
|
| Change In Working Capital |
|
0.35
+117.64%
|
-1.97
-351.15%
|
-0.44
-157.60%
|
0.76
|
| Change In Prepaid Assets |
|
-0.01
-104.32%
|
0.30
+114.56%
|
-2.07
-4000.00%
|
0.05
|
| Change In Payables And Accrued Expense |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Accrued Expense |
|
—
|
—
|
-0.20
|
0.00
|
| Change In Payable |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Account Payable |
|
0.36
+115.87%
|
-2.27
-239.06%
|
1.63
+131.68%
|
0.70
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
0.05
|
| Change In Other Current Liabilities |
|
—
|
—
|
—
|
-0.18
|
| Investing Cash Flow |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Cash Flow From Continuing Investing Activities |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Net Investment Purchase And Sale |
|
0.00
-100.00%
|
6.35
+205.50%
|
-6.02
|
0.00
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-3.06
+79.70%
|
-15.05
|
0.00
|
| Sale Of Investment |
|
0.00
-100.00%
|
9.41
+4.21%
|
9.03
|
0.00
|
| Financing Cash Flow |
|
18.56
+540.14%
|
2.90
-85.83%
|
20.47
+809.87%
|
2.25
|
| Cash Flow From Continuing Financing Activities |
|
18.56
+540.14%
|
2.90
-85.83%
|
20.47
+809.87%
|
2.25
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Net Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
0.23
-89.78%
|
2.25
|
| Net Common Stock Issuance |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.06
-82.55%
|
0.32
+542.00%
|
0.05
|
0.00
|
| Net Other Financing Charges |
|
-1.82
-178.10%
|
-0.65
+70.76%
|
-2.23
|
—
|
| Changes In Cash |
|
9.33
+256.40%
|
-5.97
-182.36%
|
7.24
+324.48%
|
-3.23
|
| Beginning Cash Position |
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
-71.09%
|
4.54
|
| End Cash Position |
|
11.92
+360.27%
|
2.59
-69.73%
|
8.56
+552.13%
|
1.31
|
| Free Cash Flow |
|
-9.23
+39.34%
|
-15.22
-111.24%
|
-7.21
-31.55%
|
-5.48
|
| Change In Interest Payable |
|
—
|
—
|
-0.20
|
0.00
|
| Common Stock Issuance |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Issuance Of Capital Stock |
|
20.32
+528.84%
|
3.23
-85.59%
|
22.43
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-30 View
- 8-K2026-03-27 View
- 10-K2026-03-27 View
- 8-K2026-03-23 View
- 8-K2026-03-06 View
- 8-K2026-03-05 View
- 8-K2026-02-13 View
- 42026-01-05 View
- 42026-01-05 View
- 8-K2025-12-05 View
- 8-K2025-12-04 View
- 8-K2025-11-06 View
- 10-Q2025-11-06 View
- 8-K2025-10-31 View
- 8-K2025-10-23 View
- 8-K2025-09-10 View
- 8-K2025-08-12 View
- 8-K2025-08-07 View
- 10-Q2025-08-07 View
- 8-K2025-08-04 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|